Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive analysis reveals XCL2 as a cancer prognosis and immune infiltration-related biomarker

30 Oct 2023

Abstract excerpt

Background: X-C Motif Chemokine Ligand 2 (XCL2) is a 114 amino acid, structurally conserved chemokine involved in activating cytotoxic T cells. However, the pathophysiological mechanisms of XCL2 protein in various disease conditions, particularly cancer, remain poorly understood. Methods: Bioinformatics was used to detect the expression of XCL2, the relationship between survival time and XCL2 in BLCA patients,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Immune cells in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37905956
DOI: 10.18632/aging.205156

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive analysis reveals XCL2 as a cancer prognosis and immune infiltration-related biomarkerPMID 37905956Read ↗

Systematic pan-cancer analysis reveals XCR1 as a Prognostic and Immunological BiomarkerSemantic proximity Read ↗

CCL5 might be a prognostic biomarker and associated with immuno-therapeutic efficacy in cancers: A pan-cancer analysisSemantic proximity Read ↗

Bioinformatic Analysis of the CXCR2 Ligands in Cancer ProcessesSemantic proximity Read ↗

Comprehensive Analysis of CCL21 in Human Tumors:A Potential Therapeutic Target Associated with Immune InfiltrationSemantic proximity Read ↗

CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical ApplicationsSemantic proximity Read ↗

An Integrative Pan-Cancer Analysis Revealing LCN2 as an Oncogenic Immune Protein in Tumor MicroenvironmentSemantic proximity Read ↗

Pan-cancer analysis reveals potential of RRM2 as a prognostic and immunological biomarker in human cancerSemantic proximity Read ↗

Comprehensive analysis of the expression profile and clinical implications of regulator of chromosome condensation 2 in pan-cancersSemantic proximity Read ↗

CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma via M2 macrophage interactions: A bioinformatic analysis of the tumor microenvironmentSemantic proximity Read ↗

Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogeneSemantic proximity Read ↗

Exploration of Prognostic Biomarkers and Therapeutic Targets in The Microenvironment of Bladder Cancer Based on CXC ChemokinesSemantic proximity Read ↗

Targeting the Atypical Chemokine Receptor 2 (ACKR2) improves the benefit of anti-PD-1 immunotherapy in melanomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.